A peptide's perspective on antigen presentation to the immune system
- PMID: 24231618
- DOI: 10.1038/nchembio.1391
A peptide's perspective on antigen presentation to the immune system
Abstract
Specific immune responses are critically dependent on protein degradation products in the form of peptides. These peptides are presented by major histocompatibility complexes (MHCs), and recognition of MHC-peptide complexes by the immune system determines successful pathogen elimination, transplant rejection, autoimmunity or death. Here we review the immune response from the peptide's perspective and discuss the fate of peptides in cells before presentation by MHC complexes. We then discuss how peptides are altered post-translationally to yield immune responses and how peptides can be engineered to achieve strong immune responses following vaccination. Although peptides are simple from a chemical perspective, they are complex in their immunological consequences.
Similar articles
-
Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules.Hum Immunol. 1997 May;54(2):137-47. doi: 10.1016/s0198-8859(97)00080-3. Hum Immunol. 1997. PMID: 9297532 Review.
-
Peptide presentation by class-I major histocompatibility complex molecules.Immunol Res. 1991;10(1):54-65. doi: 10.1007/BF02918167. Immunol Res. 1991. PMID: 1865131 Review.
-
Antigenicity and immunogenicity of synthetic peptides.Biologicals. 2001 Sep-Dec;29(3-4):209-13. doi: 10.1006/biol.2001.0308. Biologicals. 2001. PMID: 11851317 Review.
-
Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.Mol Immunol. 2016 Dec;80:41-49. doi: 10.1016/j.molimm.2016.10.012. Epub 2016 Nov 5. Mol Immunol. 2016. PMID: 27825049 Free PMC article.
-
Noncanonical peptides in complex with MHC class I.Expert Rev Vaccines. 2004 Apr;3(2):151-62. doi: 10.1586/14760584.3.2.151. Expert Rev Vaccines. 2004. PMID: 15056041 Review.
Cited by
-
Stabilization of exosome-targeting peptides via engineered glycosylation.J Biol Chem. 2015 Mar 27;290(13):8166-72. doi: 10.1074/jbc.M114.621383. Epub 2015 Feb 5. J Biol Chem. 2015. PMID: 25657008 Free PMC article.
-
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system.Genome Med. 2019 Jun 20;11(1):40. doi: 10.1186/s13073-019-0653-7. Genome Med. 2019. PMID: 31221199 Free PMC article. Review.
-
T cell responses to viral infections - opportunities for Peptide vaccination.Front Immunol. 2014 Apr 16;5:171. doi: 10.3389/fimmu.2014.00171. eCollection 2014. Front Immunol. 2014. PMID: 24795718 Free PMC article. Review.
-
Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.PLoS One. 2015 Sep 23;10(9):e0138458. doi: 10.1371/journal.pone.0138458. eCollection 2015. PLoS One. 2015. PMID: 26397953 Free PMC article.
-
Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses.Nat Commun. 2017 Nov 17;8(1):1591. doi: 10.1038/s41467-017-01661-7. Nat Commun. 2017. PMID: 29147022 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials